25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Bio-Gene Technology Ltd
Buy, Hold or Sell?

Let's analyze Bio-gene together

I guess you are interested in Bio-Gene Technology Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bio-Gene Technology Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Bio-Gene Technology Ltd

I send you an email if I find something interesting about Bio-Gene Technology Ltd.

1. Quick Overview

1.1. Quick analysis of Bio-gene (30 sec.)










1.2. What can you expect buying and holding a share of Bio-gene? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
A$0.01
Expected worth in 1 year
A$0.01
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-0.01
Return On Investment
-18.2%

For what price can you sell your share?

Current Price per Share
A$0.05
Expected price per share
A$0.045 - A$0.059
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Bio-gene (5 min.)




Live pricePrice per Share (EOD)
A$0.05
Intrinsic Value Per Share
A$-0.13 - A$-0.09
Total Value Per Share
A$-0.12 - A$-0.08

2.2. Growth of Bio-gene (5 min.)




Is Bio-gene growing?

Current yearPrevious yearGrowGrow %
How rich?$1.8m$2.1m-$282.9k-15.4%

How much money is Bio-gene making?

Current yearPrevious yearGrowGrow %
Making money-$1.5m-$2m$451.6k28.5%
Net Profit Margin-13,150.5%-520.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Bio-gene (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#764 / 959

Most Revenue
#758 / 959

Most Profit
#266 / 959

Most Efficient
#892 / 959
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Bio-gene?

Welcome investor! Bio-gene's management wants to use your money to grow the business. In return you get a share of Bio-gene.

First you should know what it really means to hold a share of Bio-gene. And how you can make/lose money.

Speculation

The Price per Share of Bio-gene is A$0.047. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bio-gene.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bio-gene, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.01. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bio-gene.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.01-16.7%-0.01-16.7%-0.01-21.5%-0.01-17.7%-0.01-13.3%
Usd Book Value Change Per Share0.00-3.0%0.00-3.0%-0.01-21.2%0.00-3.0%0.001.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.1%0.000.1%
Usd Total Gains Per Share0.00-3.0%0.00-3.0%-0.01-21.2%0.00-2.9%0.001.8%
Usd Price Per Share0.03-0.03-0.05-0.07-0.05-
Price to Earnings Ratio-4.10--4.10--5.07--9.20--6.65-
Price-to-Total Gains Ratio-22.93--22.93--5.15--2.14--5.04-
Price to Book Ratio3.54-3.54-4.88-5.00-3.35-
Price-to-Total Gains Ratio-22.93--22.93--5.15--2.14--5.04-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0309166
Number of shares32345
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (32345 shares)-45.46-43.49
Gains per Year (32345 shares)-181.83-173.95
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-182-1928-182-184
20-364-37417-365-358
30-545-55625-547-532
40-727-73834-730-706
50-909-92042-912-880
60-1091-110251-1095-1054
70-1273-128459-1277-1228
80-1455-146668-1460-1402
90-1636-164876-1642-1576
100-1818-183085-1824-1750

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.011.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.05.00.050.0%6.05.00.054.5%
Dividend per Share0.00.01.00.0%1.00.02.033.3%3.00.02.060.0%3.00.07.030.0%3.00.08.027.3%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.05.00.050.0%6.05.00.054.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Bio-Gene Technology Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.002-0.0020%-0.015+608%-0.002+0%0.001-272%
Book Value Per Share--0.0140.0140%0.016-13%0.022-38%0.022-37%
Current Ratio--8.4918.4910%6.239+36%8.908-5%15.452-45%
Debt To Asset Ratio--0.1170.1170%0.160-27%0.131-11%0.135-14%
Debt To Equity Ratio--0.1320.1320%0.191-31%0.152-13%0.185-29%
Dividend Per Share----0%-0%0.000-100%0.000-100%
Eps---0.012-0.0120%-0.015+28%-0.013+6%-0.009-21%
Free Cash Flow Per Share---0.014-0.0140%-0.016+19%-0.009-31%-0.008-43%
Free Cash Flow To Equity Per Share---0.004-0.0040%-0.017+329%0.000-94%0.002-283%
Gross Profit Margin--1.1121.1120%1.099+1%1.131-2%1.121-1%
Intrinsic Value_10Y_max---0.091--------
Intrinsic Value_10Y_min---0.130--------
Intrinsic Value_1Y_max---0.008--------
Intrinsic Value_1Y_min---0.011--------
Intrinsic Value_3Y_max---0.025--------
Intrinsic Value_3Y_min---0.035--------
Intrinsic Value_5Y_max---0.043--------
Intrinsic Value_5Y_min---0.061--------
Market Cap9464014.000-4%9866738.0009866738.0000%15706236.000-37%22431726.800-56%16350594.400-40%
Net Profit Margin---131.505-131.5050%-5.202-96%-29.213-78%-42.508-68%
Operating Margin---136.257-136.2570%-5.347-96%-30.333-78%-52.724-61%
Operating Ratio--168.165168.1650%6.874+2347%37.800+345%56.807+196%
Pb Ratio3.391-4%3.5353.5350%4.876-27%5.002-29%3.348+6%
Pe Ratio-3.928+4%-4.095-4.0950%-5.073+24%-9.196+125%-6.652+62%
Price Per Share0.047-4%0.0490.0490%0.078-37%0.111-56%0.081-40%
Price To Free Cash Flow Ratio-3.429+4%-3.575-3.5750%-4.794+34%134.150-103%64.981-106%
Price To Total Gains Ratio-21.999+4%-22.935-22.9350%-5.154-78%-2.138-91%-5.042-78%
Quick Ratio--12.23812.2380%5.988+104%11.995+2%19.808-38%
Return On Assets---0.762-0.7620%-0.807+6%-0.542-29%-0.414-46%
Return On Equity---0.863-0.8630%-0.961+11%-0.628-27%-0.496-43%
Total Gains Per Share---0.002-0.0020%-0.015+608%-0.002-4%0.001-265%
Usd Book Value--1836014.5231836014.5230%2119003.372-13%2963974.705-38%2918360.419-37%
Usd Book Value Change Per Share---0.001-0.0010%-0.010+608%-0.001+0%0.001-272%
Usd Book Value Per Share--0.0090.0090%0.011-13%0.015-38%0.014-37%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Eps---0.008-0.0080%-0.010+28%-0.008+6%-0.006-21%
Usd Free Cash Flow---1815490.505-1815490.5050%-2155185.661+19%-1246249.988-31%-1026064.528-43%
Usd Free Cash Flow Per Share---0.009-0.0090%-0.011+19%-0.006-31%-0.005-43%
Usd Free Cash Flow To Equity Per Share---0.003-0.0030%-0.011+329%0.000-94%0.001-283%
Usd Market Cap6225428.409-4%6490340.2566490340.2560%10331562.041-37%14755589.889-56%10755420.996-40%
Usd Price Per Share0.031-4%0.0320.0320%0.051-37%0.073-56%0.053-40%
Usd Profit---1584757.946-1584757.9460%-2036405.400+28%-1649097.890+4%-1234256.649-22%
Usd Revenue--12050.89612050.8960%391442.308-97%391242.732-97%264489.013-95%
Usd Total Gains Per Share---0.001-0.0010%-0.010+608%-0.001-4%0.001-265%
 EOD+3 -5MRQTTM+0 -0YOY+21 -135Y+11 -2510Y+4 -32

3.3 Fundamental Score

Let's check the fundamental score of Bio-Gene Technology Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.928
Price to Book Ratio (EOD)Between0-13.391
Net Profit Margin (MRQ)Greater than0-131.505
Operating Margin (MRQ)Greater than0-136.257
Quick Ratio (MRQ)Greater than112.238
Current Ratio (MRQ)Greater than18.491
Debt to Asset Ratio (MRQ)Less than10.117
Debt to Equity Ratio (MRQ)Less than10.132
Return on Equity (MRQ)Greater than0.15-0.863
Return on Assets (MRQ)Greater than0.05-0.762
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Bio-Gene Technology Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.139
Ma 20Greater thanMa 500.054
Ma 50Greater thanMa 1000.051
Ma 100Greater thanMa 2000.050
OpenGreater thanClose0.050
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Bio-Gene Technology Ltd

Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University to support research and field operations relating to processing and distillation of oil from biomass; AgriFor Scientific, a chemistry product; cesar for assessing the insecticidal activity of molecules against a various insect species; CSIRO, a chemistry development process; Department of Agriculture and Fisheries, Queensland Government for assessing activity against grain storage pests; Eurofins; Grain Research Development Corporation; Pacific Discovery Services; Purdue University; Southern Cross University, a chemical analysis of natural products; University of Florida; and University of Technology. It serves animal health, crop protection, grain storage, public health, and consumer applications. The company was incorporated in 1995 and is based in Melbourne, Australia.

Fundamental data was last updated by Penke on 2024-11-13 10:28:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Bio-gene earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bio-gene to the Biotechnology industry mean.
  • A Net Profit Margin of -13,150.5% means that $-131.51 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bio-Gene Technology Ltd:

  • The MRQ is -13,150.5%. The company is making a huge loss. -2
  • The TTM is -13,150.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-13,150.5%TTM-13,150.5%0.0%
TTM-13,150.5%YOY-520.2%-12,630.3%
TTM-13,150.5%5Y-2,921.3%-10,229.2%
5Y-2,921.3%10Y-4,250.8%+1,329.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13,150.5%-133.6%-13,016.9%
TTM-13,150.5%-204.9%-12,945.6%
YOY-520.2%-207.4%-312.8%
5Y-2,921.3%-353.5%-2,567.8%
10Y-4,250.8%-466.1%-3,784.7%
4.3.1.2. Return on Assets

Shows how efficient Bio-gene is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bio-gene to the Biotechnology industry mean.
  • -76.2% Return on Assets means that Bio-gene generated $-0.76 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bio-Gene Technology Ltd:

  • The MRQ is -76.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -76.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-76.2%TTM-76.2%0.0%
TTM-76.2%YOY-80.7%+4.5%
TTM-76.2%5Y-54.2%-22.1%
5Y-54.2%10Y-41.4%-12.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-76.2%-10.8%-65.4%
TTM-76.2%-11.8%-64.4%
YOY-80.7%-11.0%-69.7%
5Y-54.2%-12.6%-41.6%
10Y-41.4%-14.4%-27.0%
4.3.1.3. Return on Equity

Shows how efficient Bio-gene is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bio-gene to the Biotechnology industry mean.
  • -86.3% Return on Equity means Bio-gene generated $-0.86 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bio-Gene Technology Ltd:

  • The MRQ is -86.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -86.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-86.3%TTM-86.3%0.0%
TTM-86.3%YOY-96.1%+9.8%
TTM-86.3%5Y-62.8%-23.6%
5Y-62.8%10Y-49.6%-13.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-86.3%-13.5%-72.8%
TTM-86.3%-15.9%-70.4%
YOY-96.1%-13.5%-82.6%
5Y-62.8%-18.6%-44.2%
10Y-49.6%-19.0%-30.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Bio-Gene Technology Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Bio-gene is operating .

  • Measures how much profit Bio-gene makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bio-gene to the Biotechnology industry mean.
  • An Operating Margin of -13,625.7% means the company generated $-136.26  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bio-Gene Technology Ltd:

  • The MRQ is -13,625.7%. The company is operating very inefficient. -2
  • The TTM is -13,625.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-13,625.7%TTM-13,625.7%0.0%
TTM-13,625.7%YOY-534.7%-13,091.0%
TTM-13,625.7%5Y-3,033.3%-10,592.3%
5Y-3,033.3%10Y-5,272.4%+2,239.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13,625.7%-277.1%-13,348.6%
TTM-13,625.7%-312.9%-13,312.8%
YOY-534.7%-222.0%-312.7%
5Y-3,033.3%-385.5%-2,647.8%
10Y-5,272.4%-495.6%-4,776.8%
4.3.2.2. Operating Ratio

Measures how efficient Bio-gene is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 168.17 means that the operating costs are $168.17 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bio-Gene Technology Ltd:

  • The MRQ is 168.165. The company is inefficient in keeping operating costs low. -1
  • The TTM is 168.165. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ168.165TTM168.1650.000
TTM168.165YOY6.874+161.291
TTM168.1655Y37.800+130.365
5Y37.80010Y56.807-19.006
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ168.1652.842+165.323
TTM168.1653.198+164.967
YOY6.8743.301+3.573
5Y37.8004.800+33.000
10Y56.8076.530+50.277
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Bio-Gene Technology Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Bio-gene is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.49 means the company has $8.49 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bio-Gene Technology Ltd:

  • The MRQ is 8.491. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.491. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.491TTM8.4910.000
TTM8.491YOY6.239+2.252
TTM8.4915Y8.908-0.417
5Y8.90810Y15.452-6.544
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.4913.788+4.703
TTM8.4913.923+4.568
YOY6.2394.711+1.528
5Y8.9085.959+2.949
10Y15.4526.278+9.174
4.4.3.2. Quick Ratio

Measures if Bio-gene is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bio-gene to the Biotechnology industry mean.
  • A Quick Ratio of 12.24 means the company can pay off $12.24 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bio-Gene Technology Ltd:

  • The MRQ is 12.238. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 12.238. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ12.238TTM12.2380.000
TTM12.238YOY5.988+6.251
TTM12.2385Y11.995+0.243
5Y11.99510Y19.808-7.813
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.2383.381+8.857
TTM12.2383.526+8.712
YOY5.9884.682+1.306
5Y11.9955.922+6.073
10Y19.8086.458+13.350
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Bio-Gene Technology Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Bio-gene assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bio-gene to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.12 means that Bio-gene assets are financed with 11.7% credit (debt) and the remaining percentage (100% - 11.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bio-Gene Technology Ltd:

  • The MRQ is 0.117. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.117. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.117TTM0.1170.000
TTM0.117YOY0.160-0.043
TTM0.1175Y0.131-0.015
5Y0.13110Y0.135-0.004
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1170.338-0.221
TTM0.1170.347-0.230
YOY0.1600.310-0.150
5Y0.1310.365-0.234
10Y0.1350.381-0.246
4.5.4.2. Debt to Equity Ratio

Measures if Bio-gene is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bio-gene to the Biotechnology industry mean.
  • A Debt to Equity ratio of 13.2% means that company has $0.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bio-Gene Technology Ltd:

  • The MRQ is 0.132. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.132. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.132TTM0.1320.000
TTM0.132YOY0.191-0.059
TTM0.1325Y0.152-0.020
5Y0.15210Y0.185-0.033
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1320.387-0.255
TTM0.1320.437-0.305
YOY0.1910.375-0.184
5Y0.1520.450-0.298
10Y0.1850.489-0.304
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bio-gene generates.

  • Above 15 is considered overpriced but always compare Bio-gene to the Biotechnology industry mean.
  • A PE ratio of -4.10 means the investor is paying $-4.10 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bio-Gene Technology Ltd:

  • The EOD is -3.928. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.095. Based on the earnings, the company is expensive. -2
  • The TTM is -4.095. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.928MRQ-4.095+0.167
MRQ-4.095TTM-4.0950.000
TTM-4.095YOY-5.073+0.978
TTM-4.0955Y-9.196+5.100
5Y-9.19610Y-6.652-2.543
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.928-2.384-1.544
MRQ-4.095-2.428-1.667
TTM-4.095-2.991-1.104
YOY-5.073-3.440-1.633
5Y-9.196-6.006-3.190
10Y-6.652-6.278-0.374
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bio-Gene Technology Ltd:

  • The EOD is -3.429. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.575. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.575. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.429MRQ-3.575+0.146
MRQ-3.575TTM-3.5750.000
TTM-3.575YOY-4.794+1.219
TTM-3.5755Y134.150-137.725
5Y134.15010Y64.981+69.169
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.429-3.160-0.269
MRQ-3.575-3.222-0.353
TTM-3.575-3.516-0.059
YOY-4.794-4.582-0.212
5Y134.150-8.076+142.226
10Y64.981-8.950+73.931
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Bio-gene is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.54 means the investor is paying $3.54 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bio-Gene Technology Ltd:

  • The EOD is 3.391. Based on the equity, the company is fair priced.
  • The MRQ is 3.535. Based on the equity, the company is fair priced.
  • The TTM is 3.535. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.391MRQ3.535-0.144
MRQ3.535TTM3.5350.000
TTM3.535YOY4.876-1.341
TTM3.5355Y5.002-1.467
5Y5.00210Y3.348+1.654
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.3911.964+1.427
MRQ3.5351.983+1.552
TTM3.5352.197+1.338
YOY4.8762.404+2.472
5Y5.0023.596+1.406
10Y3.3484.223-0.875
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bio-Gene Technology Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Long-term Assets Other  -38851-33737-30045-255458203
Gross Profit  640-241400213613-331282-583-301



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets3,160
Total Liabilities368
Total Stockholder Equity2,791
 As reported
Total Liabilities 368
Total Stockholder Equity+ 2,791
Total Assets = 3,160

Assets

Total Assets3,160
Total Current Assets2,937
Long-term Assets222
Total Current Assets
Cash And Cash Equivalents 710
Short-term Investments 1,500
Net Receivables 524
Other Current Assets 204
Total Current Assets  (as reported)2,937
Total Current Assets  (calculated)2,937
+/-0
Long-term Assets
Property Plant Equipment 19
Intangible Assets 203
Long-term Assets  (as reported)222
Long-term Assets  (calculated)222
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities346
Long-term Liabilities23
Total Stockholder Equity2,791
Total Current Liabilities
Accounts payable 47
Other Current Liabilities 299
Total Current Liabilities  (as reported)346
Total Current Liabilities  (calculated)346
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)23
Long-term Liabilities  (calculated)0
+/- 23
Total Stockholder Equity
Common Stock21,525
Retained Earnings -19,640
Accumulated Other Comprehensive Income 907
Total Stockholder Equity (as reported)2,791
Total Stockholder Equity (calculated)2,791
+/-0
Other
Capital Stock21,525
Cash and Short Term Investments 2,210
Common Stock Shares Outstanding 185,818
Liabilities and Stockholders Equity 3,160
Net Debt -710
Net Invested Capital 2,791
Net Working Capital 2,591
Property Plant and Equipment Gross 56



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-30
> Total Assets 
291
435
856
9,445
7,667
5,563
6,570
5,001
7,303
3,835
3,160
3,1603,8357,3035,0016,5705,5637,6679,445856435291
   > Total Current Assets 
101
297
330
8,953
7,203
5,142
6,182
4,664
7,003
3,580
2,937
2,9373,5807,0034,6646,1825,1427,2038,953330297101
       Cash And Cash Equivalents 
51
209
102
8,793
6,707
4,499
5,522
3,933
6,342
2,991
710
7102,9916,3423,9335,5224,4996,7078,79310220951
       Short-term Investments 
0
0
0
2,000
6,400
4,300
5,300
0
74
0
1,500
1,50007405,3004,3006,4002,000000
       Net Receivables 
0
9
228
161
368
473
483
524
438
446
524
52444643852448347336816122890
       Other Current Assets 
50
88
228
161
70
74
74
74
74
74
204
2047474747474701612288850
   > Long-term Assets 
190
139
527
492
463
421
388
337
300
255
222
222255300337388421463492527139190
       Property Plant Equipment 
8
7
28
30
39
33
37
23
23
15
19
19152323373339302878
       Intangible Assets 
182
132
499
462
425
388
351
314
277
240
203
203240277314351388425462499132182
> Total Liabilities 
1
0
383
374
760
614
567
755
1,035
614
368
3686141,03575556761476037438301
   > Total Current Liabilities 
1
0
7
224
610
464
412
593
1,009
574
346
3465741,009593412464610224701
       Short-term Debt 
0
0
0
0
0
0
12
0
0
0
0
000012000000
       Accounts payable 
0
0
7
224
185
123
134
88
219
119
47
4711921988134123185224700
       Other Current Liabilities 
1
0
7
403
425
340
266
505
790
455
299
299455790505266340425403701
   > Long-term Liabilities 
0
0
376
150
150
150
155
162
25
40
23
23402516215515015015037600
       Long term Debt Total 
0
0
0
150
150
150
150
150
0
0
0
000150150150150150000
       Other Liabilities 
0
0
376
150
150
150
155
162
25
0
0
002516215515015015037600
> Total Stockholder Equity
290
435
473
9,071
6,907
4,949
6,002
4,246
6,268
3,221
2,791
2,7913,2216,2684,2466,0024,9496,9079,071473435290
   Common Stock
1,265
1,550
1,779
11,956
11,769
11,804
14,536
15,062
19,546
19,546
21,525
21,52519,54619,54615,06214,53611,80411,76911,9561,7791,5501,265
   Retained Earnings -19,640-17,432-14,499-11,679-9,483-7,551-5,495-2,960-1,607-1,115-975
   Capital Surplus 00000000000
   Treasury Stock00000000000
   Other Stockholders Equity 
0
0
301
366
634
696
950
863
1,222
818
0
08181,22286395069663436630100



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.




5.6. Income Statements

Currency in AUD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue18
Cost of Revenue-320
Gross Profit-301-301
 
Operating Income (+$)
Gross Profit-301
Operating Expense-2,761
Operating Income-3,062-3,062
 
Operating Expense (+$)
Research Development1,070
Selling General Administrative1,420
Selling And Marketing Expenses271
Operating Expense2,7612,761
 
Net Interest Income (+$)
Interest Income87
Interest Expense-0
Other Finance Cost-0
Net Interest Income87
 
Pretax Income (+$)
Operating Income-3,062
Net Interest Income87
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,409-3,716
EBIT - interestExpense = -2,496
-3,013
-2,409
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-2,496-2,409
Earnings Before Interest and Taxes (EBITDA)-2,458
 
After tax Income (+$)
Income Before Tax-2,409
Tax Provision-0
Net Income From Continuing Ops-2,409-2,409
Net Income-2,409
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses3,081
Total Other Income/Expenses Net653-87
 

Technical Analysis of Bio-gene
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bio-gene. The general trend of Bio-gene is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bio-gene's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bio-Gene Technology Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.053 < 0.058 < 0.059.

The bearish price targets are: 0.05 > 0.045 > 0.045.

Tweet this
Bio-Gene Technology Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bio-Gene Technology Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bio-Gene Technology Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bio-Gene Technology Ltd. The current macd is -0.00021403.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bio-gene price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bio-gene. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bio-gene price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Bio-Gene Technology Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBio-Gene Technology Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bio-Gene Technology Ltd. The current adx is 19.43.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bio-gene shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Bio-Gene Technology Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bio-Gene Technology Ltd. The current sar is 0.05879286.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bio-Gene Technology Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bio-Gene Technology Ltd. The current rsi is 32.14. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Bio-Gene Technology Ltd Daily Relative Strength Index (RSI) ChartBio-Gene Technology Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bio-Gene Technology Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bio-gene price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Bio-Gene Technology Ltd Daily Stochastic Oscillator ChartBio-Gene Technology Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bio-Gene Technology Ltd. The current cci is -287.76462146.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Bio-Gene Technology Ltd Daily Commodity Channel Index (CCI) ChartBio-Gene Technology Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bio-Gene Technology Ltd. The current cmo is -54.46790832.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bio-Gene Technology Ltd Daily Chande Momentum Oscillator (CMO) ChartBio-Gene Technology Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bio-Gene Technology Ltd. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Bio-Gene Technology Ltd Daily Williams %R ChartBio-Gene Technology Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bio-Gene Technology Ltd.

Bio-Gene Technology Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bio-Gene Technology Ltd. The current atr is 0.0015889.

Bio-Gene Technology Ltd Daily Average True Range (ATR) ChartBio-Gene Technology Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bio-Gene Technology Ltd. The current obv is -7,486,450.

Bio-Gene Technology Ltd Daily On-Balance Volume (OBV) ChartBio-Gene Technology Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bio-Gene Technology Ltd. The current mfi is 9.04152143.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Bio-Gene Technology Ltd Daily Money Flow Index (MFI) ChartBio-Gene Technology Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bio-Gene Technology Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-12STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Bio-Gene Technology Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bio-Gene Technology Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.139
Ma 20Greater thanMa 500.054
Ma 50Greater thanMa 1000.051
Ma 100Greater thanMa 2000.050
OpenGreater thanClose0.050
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Bio-gene with someone you think should read this too:
  • Are you bullish or bearish on Bio-gene? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bio-gene? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bio-Gene Technology Ltd

I send you an email if I find something interesting about Bio-Gene Technology Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Bio-Gene Technology Ltd.

Receive notifications about Bio-Gene Technology Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.